GoodRx Holdings (GDRX) Equity Ratio (2019 - 2026)

GoodRx Holdings has disclosed Equity Ratio across 8 years of filings, most recently posting 0.31 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.31, down 39.09% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.31 (down 39.09% YoY), and the FY2025 annual result was 0.44, down 15.93% from the prior year.
• Equity Ratio came in at 0.31 for Q1 2026 at GoodRx Holdings, down from 0.44 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.53 in Q2 2023 to a low of 0.31 in Q1 2026.
• The 5-year median for Equity Ratio is 0.51 (2025), against an average of 0.48.
• Across the five-year window, Equity Ratio gained 16.39% in 2025 and sank 39.09% in 2026, its largest moves.
• GoodRx Holdings' Equity Ratio stood at 0.51 in 2022, then retreated by 5.56% to 0.48 in 2023, then grew by 8.86% to 0.52 in 2024, then decreased by 15.93% to 0.44 in 2025, then slipped by 29.89% to 0.31 in 2026.
• The last three Equity Ratio figures came in at 0.31 (Q1 2026), 0.44 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.